PEP-Therapy and Institut Curie granted approval from ANSM to start first-in-human clinical trial of ...

Retrieved on: 2021-03-16 12:22:30

Tags for this article:

Click the tags to see associated articles and topics

PEP-Therapy and Institut Curie granted approval from ANSM to start first-in-human clinical trial of .... View article details on hiswai:

Excerpt

PARIS, March 16, 2021 /PRNewswire/ -- PEP-Therapy, a biotechnology company developing cell penetrating peptides as targeted therapies in ...

Article found on: www.prnewswire.com